BRD4 and colorectal carcinoma: The findings described in this article support the involvement of BRD4 in the pathogenesis of IBDs and CRC, given that the expression of BRD4 is up-regulated in the affected tissues of those patients, and inhibition of BRD4 expression/function attenuates the pathological process in murine models of IBDs and CRC (Table 1).